T3D Therapeutics, Inc. Email Format

Pharmaceutical ManufacturingNorth Carolina, United States11-50 Employees

T3D Therapeutics, Inc. is a pharmaceutical development company based in Durham, North Carolina, focused on advancing therapies for neurodegenerative diseases. Its lead candidate, T3D-959, is being developed as an oral medicine aimed at slowing, stopping, or potentially reversing the progression of Alzheimer's disease, with research efforts also exploring applications in Huntington’s disease models. The company operates within the clinical-stage space, pursuing disease-modifying approaches that could offer meaningful changes in the trajectory of neurodegenerative conditions. Founded and positioned as a small to mid-size biotech firm, T3D Therapeutics concentrates its activities on preclinical and early-stage clinical work to establish the utility of its therapeutic program. A recent development includes continued advancement of its program in the context of Alzheimer’s disease research and exploration of additional disease areas in preclinical studies.

Get verified T3D Therapeutics, Inc. emails free

Company overview Employee directory